It depends what the drug is treating, and since July there is a third answer that did not exist before.
Does Medicare cover Ozempic?
For type 2 diabetes, yes, in the ordinary way: Medicare Part D plans can and do cover Ozempic when it is treating blood sugar, subject to your specific plan's formulary, tier and prior-authorisation rules. Mounjaro sits in the same position for the same reason. This route is long-established and it is why coverage for the diabetes brands has always been easier than for the weight ones.
For weight loss, taking Ozempic off-label, no. That is not your plan being difficult; it is the indication.
Does Medicare cover Wegovy?
Historically no, because Wegovy is indicated for weight management. As of 1 July 2026 there is a programme that changes the practical answer, and it is worth reading Novo's own description of it:1
The Medicare GLP-1 Bridge is a temporary program starting July 1, 2026. It helps eligible Medicare Part D members access certain GLP-1 weight-loss medications, including Wegovy. ... The Medicare GLP-1 Bridge program currently covers all doses of Wegovy — both pen and pill — for $50 per month, as well as some forms and doses of other GLP-1 weight-loss medications.
Novo Nordisk
What an eligible Medicare Part D beneficiary pays for any dose of the Wegovy pen or pill under the Bridge, through 31 December 2027.
The two things about the Bridge nobody explains
Both are in Novo's own FAQ and both change how you should think about it:2
No. The Medicare GLP-1 Bridge program works outside of Medicare Part D. Your Medicare drug plan does not review, approve, or pay for prescriptions covered through this program.
Novo Nordisk
It is not your plan. You do not enrol, your plan does not adjudicate it, and pharmacies do not have to opt in. Your prescriber and your pharmacist run it, and the pharmacy gives your Medicare Number (the one on the red and blue card, not a Part D number) to a separate system.
The $50 per month copay will not count toward your Medicare Part D deductible or total out-of-pocket costs, since the Medicare GLP-1 Bridge is a separate program.
Novo Nordisk
And it does not move you through your Part D year. Twelve months of Bridge fills is $600 that does nothing for your deductible or your out-of-pocket maximum. If you have other expensive drugs on Part D, that matters, and it is the kind of thing you want to know before December rather than after.
Novo is explicit that eligibility is CMS's call, not theirs: "Eligibility criteria will be determined by Centers for Medicare & Medicaid Services (CMS). This information is not a guarantee of coverage." Nothing on this page is either.
Why it is called a Bridge
Because something else was supposed to happen and did not.
CMS and its innovation centre built a model called BALANCE to put GLP-1s inside Medicare and Medicaid properly. It covers all formulations of Foundayo, Mounjaro, Ozempic, Rybelsus and Wegovy plus the Zepbound KwikPen, and participation is voluntary for manufacturers, state Medicaid agencies and Part D plans.3 Its Medicaid arm started on 1 May 2026. Its Medicare Part D arm was indefinitely delayed.
A manufacturer-run programme that sits outside Part D, is explicitly temporary, and is called a Bridge began two months after that delay. We are not going to assert the two are formally connected, because we have not seen that stated. The sequence is worth knowing when you are deciding how much to plan around a programme with an end date on it.
Who qualifies
Per Novo: you must be enrolled in a standalone Part D prescription drug plan or a Medicare Advantage plan with drug coverage, be 18 or over, and meet medical criteria your prescriber assesses.1 The programme is temporary and currently runs to 31 December 2027.
There is no sign-up. It starts with a prescriber deciding the drug is right for you, and then a prior-authorisation process run between the pharmacy and the programme. Novo staffs a support line for it at 888-809-3942, weekdays 8am to 8pm ET.
Why the $25 coupons will not work for you
This trips people up constantly, and the wording is unambiguous:3
Pay as little as $25, subject to a maximum savings of $100/month. Government beneficiaries excluded.
NovoCare
"Government beneficiaries" means Medicare and Medicaid. Manufacturer copay cards cannot be combined with government drug coverage, and this is industry-wide rather than a Novo quirk. Lilly's Zepbound and Mounjaro cards say the same. So the ordinary coupon route is closed to you, and the Bridge exists precisely because it was.
What Medicare does not cover, and what it costs then
If you do not qualify, or you are on a drug the Bridge does not include, you are paying cash, and the spread is wide:
Worth reading alongside what every route costs without insurance, since the arithmetic is the same once a plan is out of the picture.
What to actually do
- If you have type 2 diabetes, the on-label diabetes brands are the far easier coverage conversation. Start there with your prescriber.
- If weight is the indication, ask specifically about the Medicare GLP-1 Bridge by name. It is new enough that not every office is fluent in it, and the process runs through your pharmacy.
- Check what your own plan publishes. We keep the major insurers' own coverage statements with quotes and dates, and formularies differ.
- Diarise the end date. The Bridge is temporary and currently runs to 31 December 2027.